CHA Bundang Medical Center, CHA University

Seongnam-si, Gyeonggido 463-712

3 studies enrolling now · 18 studies all time

What they study most

Advanced Solid Tumor, Biliary Tract Cancer, Branch Retinal Vein Occlusion, Breast Cancer, Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Macular Edema (DME), First Line Non-Small Cell Lung Cancer, Hemi-retinal Vein Occlusion, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, MET Gene Amplification

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling
• A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer — Running, not enrolling
• ABTECT - Maintenance — Running, not enrolling
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema — Running, not enrolling
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration — Running, not enrolling
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer — Stopped early
• Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer — Stopped early
• Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies — Completed
• Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis — Completed